Renal gene and protein expression signatures for prediction of kidney disease progression.

Although chronic kidney disease (CKD) is common, only a fraction of CKD patients progress to end-stage renal disease. Molecular predictors to stratify CKD populations according to their risk of progression remain undiscovered. Here we applied transcriptional profiling of kidneys from transforming growth factor-beta1 transgenic (Tg) mice, characterized by heterogeneity of kidney disease progression, to identify 43 genes that discriminate kidneys by severity of glomerular apoptosis before the onset of tubulointerstitial fibrosis in 2-week-old animals. Among the genes examined, 19 showed significant correlation between mRNA expression in uninephrectomized left kidneys at 2 weeks of age and renal disease severity in right kidneys of Tg mice at 4 weeks of age. Gene expression profiles of human orthologs of the 43 genes in kidney biopsies were highly significantly related (R(2) = 0.53; P < 0.001) to the estimated glomerular filtration rates in patients with CKD stages I to V, and discriminated groups of CKD stages I/II and III/IV/V with positive and negative predictive values of 0.8 and 0.83, respectively. Protein expression patterns for selected genes were successfully validated by immunohistochemistry in kidneys of Tg mice and kidney biopsies of patients with IgA nephropathy and CKD stages I to V, respectively. In conclusion, we developed novel mRNA and protein expression signatures that predict progressive renal fibrosis in mice and may be useful molecular predictors of CKD progression in humans.

[1]  I. Higuchi [Collagen VI-related muscle disorders]. , 2011, Brain and nerve = Shinkei kenkyu no shinpo.

[2]  Lajos Pusztai,et al.  Gene expression profiling of breast cancer , 2009, Breast Cancer Research.

[3]  W. Ju,et al.  Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease , 2008, Proceedings of the National Academy of Sciences.

[4]  B. Brenner,et al.  Renal risk scores: progress and prospects. , 2008, Kidney international.

[5]  T. Hostetter,et al.  Staging of chronic kidney disease: time for a course correction. , 2008, Journal of the American Society of Nephrology : JASN.

[6]  S. Paik,et al.  S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase‐3 activity in Hep3B cells , 2008, Journal of cellular biochemistry.

[7]  Jian Yu,et al.  Downregulation of Dkk3 activates β-catenin/TCF-4 signaling in lung cancer , 2008 .

[8]  Jian Yu,et al.  Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. , 2008, Carcinogenesis.

[9]  C. Niehrs,et al.  Dkk3 is required for TGF‐β signaling during Xenopus mesoderm induction , 2007 .

[10]  C. Heizmann,et al.  S100B and S100A6 Differentially Modulate Cell Survival by Interacting with Distinct RAGE (Receptor for Advanced Glycation End Products) Immunoglobulin Domains* , 2007, Journal of Biological Chemistry.

[11]  S. Chadban,et al.  TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.

[12]  Arnoldo Frigessi,et al.  BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm305 Gene expression Predicting survival from microarray data—a comparative study , 2022 .

[13]  E. Bottinger TGF-β in renal injury and disease , 2007 .

[14]  B. Freedman,et al.  Familial Clustering of Chronic Kidney Disease , 2007, Seminars in dialysis.

[15]  H. Dressman,et al.  Gene Expression Signatures That Predict Radiation Exposure in Mice and Humans , 2007, PLoS medicine.

[16]  E. Böttinger TGF-beta in renal injury and disease. , 2007, Seminars in nephrology.

[17]  C. Niehrs,et al.  Dkk3 is required for TGF-beta signaling during Xenopus mesoderm induction. , 2007, Differentiation; research in biological diversity.

[18]  R. Schwabe,et al.  TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.

[19]  Tanja Popovic,et al.  Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004. , 2007, MMWR. Morbidity and mortality weekly report.

[20]  B. Brenner,et al.  Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. , 2006, Kidney international.

[21]  Felix Eichinger,et al.  Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.

[22]  R. Lu,et al.  Luman/CREB3 Induces Transcription of the Endoplasmic Reticulum (ER) Stress Response Protein Herp through an ER Stress Response Element , 2006, Molecular and Cellular Biology.

[23]  C. Langefeld,et al.  Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus. , 2006, Hypertension.

[24]  C. Cohen,et al.  Gene expression profiling analysis in nephrology: towards molecular definition of renal disease , 2006, Clinical and Experimental Nephrology.

[25]  R. Kucherlapati,et al.  Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation , 2006, Molecular and Cellular Biology.

[26]  Youhua Liu,et al.  Renal fibrosis: new insights into the pathogenesis and therapeutics. , 2006, Kidney international.

[27]  Wei-Hwa Lee,et al.  Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. , 2005, Kidney international.

[28]  S. Snyder,et al.  Detection and evaluation of chronic kidney disease. , 2005, American family physician.

[29]  Giuseppe Remuzzi,et al.  Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. , 2005, Kidney international. Supplement.

[30]  T. Kita,et al.  Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. , 2005, Kidney international.

[31]  W. Scott,et al.  The TGF‐β1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes , 2005 .

[32]  W. Scott,et al.  The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes. , 2005, Diabetic Medicine.

[33]  A. Shaw,et al.  A Novel Role for the Adaptor Molecule CD2-associated Protein in Transforming Growth Factor-β-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[34]  Paul Marjoram,et al.  A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus , 2004, Oncogene.

[35]  C. Cohen,et al.  Gene expression analysis in renal biopsies. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  M. Suthanthiran,et al.  Transforming growth factor beta and progression of renal disease. , 2003, Kidney international. Supplement.

[37]  R. Kucherlapati,et al.  Hierarchical model of gene regulation by transforming growth factor β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  X. Wang,et al.  Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.

[39]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[40]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[41]  D. Salant,et al.  Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. , 2002, The Journal of clinical investigation.

[42]  J. Zavadil,et al.  Applications for Microarrays in Renal Biology and Medicine , 2002, Nephron Experimental Nephrology.

[43]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  G. Bakris,et al.  Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease , 2002, Vascular medicine.

[45]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .

[46]  C. Cohen,et al.  Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. , 2002, Kidney international.

[47]  E. Bottinger,et al.  Apoptosis in podocytes induced by TGF-β and Smad7 , 2001 .

[48]  M K Kerr,et al.  Bootstrapping cluster analysis: Assessing the reliability of conclusions from microarray experiments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Bitzer,et al.  Apoptosis in podocytes induced by TGF-beta and Smad7. , 2001, The Journal of clinical investigation.

[50]  Arthur E. Hoerl,et al.  Ridge Regression: Biased Estimation for Nonorthogonal Problems , 2000, Technometrics.

[51]  E. Bottinger,et al.  A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA , 2000, Genes & Development.

[52]  M. Bitzer,et al.  A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. , 2000, Genes & development.

[53]  Jeffrey B. Kopp,et al.  TGF- and fibrosis , 1999 .

[54]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[55]  M. Bitzer,et al.  Transforming Growth Factor-β in Renal Disease , 1998, Kidney and Blood Pressure Research.

[56]  M. Bitzer,et al.  Transforming growth factor-beta in renal disease. , 1998, Kidney & blood pressure research.

[57]  B. Padanilam,et al.  Induction of calcyclin after ischemic injury to rat kidney. , 1997, The American journal of physiology.

[58]  S. Thorgeirsson,et al.  Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[59]  M. Sporn,et al.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[60]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[61]  W. Border,et al.  Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.

[62]  R. Jaenisch,et al.  Transgenic mouse model of kidney disease: Insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome , 1990, Cell.

[63]  E. Lewis,et al.  The importance of sample size in the interpretation of the renal biopsy. , 1988, American journal of nephrology.